For COVID Drugs, Months of Frantic Development Lead to Few Outright Successes - IDEX Health & ScienceIDEX Health & Science

    Disclaimer:

    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    For COVID Drugs, Months of Frantic Development Lead to Few Outright Successes

    Article obtained from Scientific American RSS Feed.

    There have been mixed results as researchers try to stop a disease they are still trying to understand

    — Read more on ScientificAmerican.com

    READ MORE
    Nov, 13 2020 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.